Egypt Approves NUBEQA for Prostate Cancer with Hormonal Therapy

The Egyptian Drug Authority has approved a new application for Bayer's drug NUBEQA. This approval allows NUBEQA to be used for prostate cancer treatment when combined solely with hormonal therapy.

18 May, 11:51 — 18 May, 11:51

Post Share

Sources

Showing 1 of 1 sources

Ahram OnlineMixed27d ago

With the approval of the Egyptian Drug Authority, Bayer supports a new use of “NUBEQA” for prostate cancer with hormonal therapy alone - Health - Egypt - Ahram Online

With the approval of the Egyptian Drug Authority, Bayer supports a new use of “NUBEQA” for prostate cancer with hormonal therapy alone - Health - Egypt Ahram Online

Read full article →

PERSPECTA

PERSPECTA

Egypt Approves NUBEQA for Prostate Cancer with Hormonal Therapy

Sources

With the approval of the Egyptian Drug Authority, Bayer supports a new use of “NUBEQA” for prostate cancer with hormonal therapy alone - Health - Egypt - Ahram Online

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

SBMA Port Operations Revenue Climbs 20% in Q1 2026

EU Highlights Nigeria's Creative Industry as Key for Youth Employment

Elon Musk Predicts SpaceX Will Reach $1 Trillion in Annual Revenue by 2030

PERSPECTA